|
Quantity
|
Out of stock
|
||
|
|
|||
An animal’s body produces enzymes to break down fats, carbohydrates, and proteins obtained from food. In cases of pancreatic disease, the amount of produced enzymes decreases (enzymatic insufficiency), and there is a need to supplement the missing enzymes.
AmylaDol mini contains natural enzymes: lipase, amylase, and protease. The level of lipase in one tablet significantly exceeds that of amylase and protease — this is because, in pancreatic disorders, the lipase level drops much faster than the levels of amylase and protease.
Dolfos AmylaDol mini is recommended for digestive disorders in cats and small breed dogs related to chronic pancreatic insufficiency.
Features and Benefits:
- contains amylase — an enzyme that breaks down starch into oligosaccharides;
- lipase — an enzyme that, together with bile in the stomach, breaks down fats, fatty acids, and fat-soluble vitamins A, D, E, K, converting them into energy and warmth;
- protease — a pancreatic enzyme that breaks peptide bonds between amino acids in proteins;
- ensures effective digestion of fats, proteins, and carbohydrates;
- recommended for cats suffering from or prone to pancreatitis;
- for digestive disturbances;
- as monotherapy for maldigestion syndrome (nausea, diarrhea, flatulence, burping, discomfort in the abdominal area).
Composition:
Brewer’s yeast, maltodextrin.
Each mini-tablet contains:
- Amylase — 4,470 Ph.Eur.u
- Lipase — 3,070 Ph.Eur.u
- Protease — 320 Ph.Eur.u
Ph.Eur.u — European Pharmacopoeia unit
Analytical Constituents:
- Crude protein — 0.5%
- Crude fiber — 0.2%
- Crude ash — 35.4%
- Oil and crude fat — 0%
Administration and Dosage:
- Cats and small breed dogs — 1–3 mini-tablets per day
The product should be administered in the morning before feeding. The recommended duration of use is from 3 to 12 weeks. However, in cases of chronic pancreatic insufficiency, the product is prescribed for lifelong use.
Packaging: 90 tablets
Manufacturer: Dolfos, Dolfos Sp. z o.o. Sp. k., Poland


